Klapperich Lab:Notebook/Lab Meeting Notes/2009/08/25: Difference between revisions
Line 51: | Line 51: | ||
† Biointerfaces group <br> | † Biointerfaces group <br> | ||
* New fabrcation in process. <br> | * New fabrcation in process. <br> | ||
* took SEM images of parallelized designs, will show them if possible in the meeting. <br> | |||
* Through SEM images, we found the smallest feature size is 1.2 um. <br> | |||
<br> | <br> | ||
† CIMIT- Colson Grant<br> | † CIMIT- Colson Grant<br> |
Revision as of 14:33, 24 August 2009
Project name | <html><img src="/images/9/94/Report.png" border="0" /></html> Main project page <html><img src="/images/c/c3/Resultset_previous.png" border="0" /></html>Previous entry<html> </html>Next entry<html><img src="/images/5/5c/Resultset_next.png" border="0" /></html> |
25 August 2009 Lab Meeting
† Flu R01
* Need to update IBC to include rDNA work. † Virus concentration (upstream from the assay.)
† COBRA
paper 1: Evap with Sol Gel substrate.
* on-chip PCR on a series of diluted lambda phage DNA. the detect limitation for ABI is 10-9g/ul on-chip PCR have the same sensitivity. * With new syring and tubing, on-chip PCR for the patient sample does not have detectable amplified product. however, the postitive control on the thermal cycle works good. † RCA/HDA
|